Cargando…
In vitro assessment of antitumor activities of the PI3K/mTOR inhibitor GSK2126458
BACKGROUND: Up-regulation of the PI3K/mTOR (phosphatidylinositol-3′ kinase/mammalian target of rapamycin) signaling is common in carcinoma. Consistently, targeting these molecules has been shown to halt the growth of many tumors. The main purpose of this study was to develop surrogate biomarkers of...
Autores principales: | Albawardi, Alia, Al Ayyan, Muna, Al Bashir, Mohamed, Souid, Abdul-Kader, Almarzooqi, Saeeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189195/ https://www.ncbi.nlm.nih.gov/pubmed/25298748 http://dx.doi.org/10.1186/s12935-014-0090-z |
Ejemplares similares
-
Effects of molecularly targeted therapies on murine thymus: highly selective mTOR inhibitors induce reversible thymic involution
por: Al-Hammadi, Suleiman, et al.
Publicado: (2016) -
A preparation of murine liver fragments for in vitro studies: liver preparation for toxicological studies
por: Alfazari, Ali S, et al.
Publicado: (2013) -
Bioenergetic study of murine hepatic tissue treated in vitro with atorvastatin
por: Alfazari, Ali S, et al.
Publicado: (2013) -
Effect of Sirolimus/Metformin Co-Treatment on Hyperglycemia and Cellular Respiration in BALB/c Mice
por: Albawardi, Alia, et al.
Publicado: (2023) -
The dual PI3K/mTOR inhibitor GSK2126458 is effective for treating solid renal tumours in Tsc2(+/-) mice through suppression of cell proliferation and induction of apoptosis
por: Narov, Kalin, et al.
Publicado: (2017)